NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness
2021 · Journal for ImmunoTherapy of Cancer · 57 citations
https://doi.org/10.1136/jitc-2021-002866
L
Lorena Pérez-Amill
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(ES)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
137
Papers
496
Citations
11
h-index
11
i10-index
Lorena Pérez-Amill is an academic researcher from Consorci Institut D'Investigacions Biomediques August Pi I Sunyer. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & CAR-T cell therapy research & Protein Degradation and Inhibitors. The author has an h-index of 11, co-authored 117 publications.
ORCID: 0000-0003-0674-4660Papers by this author
worksData from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7234937
Data from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7234937.v1
Supplementary Figure S12 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25826729
Supplementary Figure S13 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25826726
Supplementary Figure S10 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25826735.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat